Stocks News

LAST PRICE
27.7600
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
27.8200/ 5
Ask / Lots
27.8300/ 4
Open / Previous Close
--- / 27.7600
Day Range
---
52 Week Range
Low 25.2000
High 31.5400
Volume
25,270
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: PFE, BNTX
  01:07 PM EST, 11/04/2024 (MT Newswires) -- BioNTech (BNTX) said on Monday that it expects full-year revenue at the low end of its guidance due in part to inventory write-downs, even as variant-adapted COVID-19 vaccines helped the German drugmaker ad...
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference, from 21 hours ago by Dow Jones
  21 hours ago by Dow Jones
  Companies Mentioned: PFE
  
  Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
  NEW YORK--(BUSINESS WIRE)--November 04, 2024--
  Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S. Commercial Officer, Executive Vice President, at the UBS Global Healthcare Conference on Wednesday, November 13, 2024 at 12:30 p.m. PST.
Oct 30, 2024
- Goldman Sachs Adjusts Price Target on Pfizer to $33 From $32, from 8:21AM ET on Wednesday Oct 30, 2024 by MT Newswires
  8:21AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: PFE
  08:21 AM EDT, 10/30/2024 (MT Newswires) -- Pfizer (PFE) has an average outperform rating and a price target range of $27 to $45, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major bank...
- Morgan Stanley Adjusts Price Target on Pfizer to $31 From $30, Maintains Equalweight Rating, from 6:42AM ET on Wednesday Oct 30, 2024 by MT Newswires
  6:42AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: PFE
  06:42 AM EDT, 10/30/2024 (MT Newswires) -- Pfizer (PFE) has an average rating of outperform and price targets ranging from $27 to $45, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from majo...
Oct 29, 2024
- Sector Update: Health Care Stocks Ease Late Afternoon, from 3:55PM ET on Tuesday Oct 29, 2024 by MT Newswires
  3:55PM ET on Tuesday Oct 29, 2024 by MT Newswires
  Companies Mentioned: PFE, THC, HOTH, COYA
  03:55 PM EDT, 10/29/2024 (MT Newswires) -- Health care stocks were edging lower late Tuesday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%. The iShares Biotechnology ETF (IBB) shed...

Yesterday
- --Leerink Partners Adjusts Bristol-Myers Squibb Price Target to $55 From $53, Maintains Market Perform Rating, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: BMY
Nov 1, 2024
- DJ Vir Shares Rally 25% on Cancer Licensing Deal With Sanofi, Trial Updates, from 3:05PM ET on Friday Nov 01, 2024 by Dow Jones
  3:05PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: SNY, VIR
- DJ Merck Is Maintained at Equal-Weight by Wells Fargo, from 2:55PM ET on Friday Nov 01, 2024 by Dow Jones
  2:55PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MRK
- Sector Update: Health Care Stocks Higher Friday Afternoon, from 2:01PM ET on Friday Nov 01, 2024 by MT Newswires
  2:01PM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: MRK, TOVX, WAT, CAH
- DJ Merck Is Maintained at Outperform by BMO Capital, from 12:17PM ET on Friday Nov 01, 2024 by Dow Jones
  12:17PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MRK
- DJ Bristol-Myers Squibb Is Maintained at Market Perform by BMO Capital, from 11:46AM ET on Friday Nov 01, 2024 by Dow Jones
  11:46AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: BMY
- Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, from 11:35AM ET on Friday Nov 01, 2024 by MT Newswires
  11:35AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: BMY
- JPMorgan Chase Adjusts Price Target on Bristol-Myers Squibb to $64 From $60, from 11:34AM ET on Friday Nov 01, 2024 by MT Newswires
  11:34AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: BMY
- BMO Capital Adjusts Price Target on Bristol-Myers Squibb to $57 From $53, from 10:41AM ET on Friday Nov 01, 2024 by MT Newswires
  10:41AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: BMY
- UBS Adjusts Price Target on Merck to $125 From $136, Maintains Buy Rating, from 10:15AM ET on Friday Nov 01, 2024 by MT Newswires
  10:15AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: MRK

Pfizer Inc
NYSE:PFEUnited States

Search Criteria

Yesterday

BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 18 hours ago by MT Newswires

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference, from 21 hours ago by Dow Jones

Oct 30, 2024

Goldman Sachs Adjusts Price Target on Pfizer to $33 From $32, from 8:21AM ET on Wednesday Oct 30, 2024 by MT Newswires

Morgan Stanley Adjusts Price Target on Pfizer to $31 From $30, Maintains Equalweight Rating, from 6:42AM ET on Wednesday Oct 30, 2024 by MT Newswires

Oct 29, 2024

Sector Update: Health Care Stocks Ease Late Afternoon, from 3:55PM ET on Tuesday Oct 29, 2024 by MT Newswires

Peers Headlines

Yesterday

--Leerink Partners Adjusts Bristol-Myers Squibb Price Target to $55 From $53, Maintains Market Perform Rating, from 21 hours ago by MT Newswires

Nov 1, 2024

DJ Vir Shares Rally 25% on Cancer Licensing Deal With Sanofi, Trial Updates, from 3:05PM ET on Friday Nov 01, 2024 by Dow Jones

DJ Merck Is Maintained at Equal-Weight by Wells Fargo, from 2:55PM ET on Friday Nov 01, 2024 by Dow Jones

Sector Update: Health Care Stocks Higher Friday Afternoon, from 2:01PM ET on Friday Nov 01, 2024 by MT Newswires

DJ Merck Is Maintained at Outperform by BMO Capital, from 12:17PM ET on Friday Nov 01, 2024 by Dow Jones

DJ Bristol-Myers Squibb Is Maintained at Market Perform by BMO Capital, from 11:46AM ET on Friday Nov 01, 2024 by Dow Jones

Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, from 11:35AM ET on Friday Nov 01, 2024 by MT Newswires

JPMorgan Chase Adjusts Price Target on Bristol-Myers Squibb to $64 From $60, from 11:34AM ET on Friday Nov 01, 2024 by MT Newswires

BMO Capital Adjusts Price Target on Bristol-Myers Squibb to $57 From $53, from 10:41AM ET on Friday Nov 01, 2024 by MT Newswires

UBS Adjusts Price Target on Merck to $125 From $136, Maintains Buy Rating, from 10:15AM ET on Friday Nov 01, 2024 by MT Newswires